phrykt

Profound Medical Corp. (PROF): who owns it and who trades it

As of Nov 12, 2026, no open-market insider purchases or sales of PROF were reported in the last 12 months. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 12, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Profound Medical

From the latest filings

Overall: more buying than selling. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns PROF

55 funds and institutions reported PROF shares worth $105M at the end of Q2 2026, about 44% of the company. The largest holder is FIL Ltd with 6.5%.

Funds and institutions (13F) 44%Everyone else 56%

10 largest owners, by share of the company

FIL Ltd6.5%
Gagnon Securities LLC5.4%
Royce & Associates LP3.3%
Timelo Investment Management Inc.3.1%
Gagnon Advisors, LLC2.7%
Letko, Brosseau & Associates Inc2.6%
First Eagle Investment Management, LLC2.4%
Rosalind Advisors, Inc.2.3%
Z3 Capital Partners, LLC2.3%
MMCAP International Inc. SPC1.8%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
FIL Ltd2.37M6.53%$15.8M+1%
Gagnon Securities LLC1.96M5.40%$13M+1%
Royce & Associates LP1.20M3.31%$8M+7%
Timelo Investment Management Inc.1.11M3.07%$7.4MNo change
Gagnon Advisors, LLC962,1862.65%$6.4MNo change
Letko, Brosseau & Associates Inc935,7252.58%$5.4M-2%
First Eagle Investment Management, LLC880,4142.43%$5.9M+173%
Rosalind Advisors, Inc.828,1182.28%$5.5MNo change
Z3 Capital Partners, LLC820,9412.26%$5.5M+0%
MMCAP International Inc. SPC671,3561.85%$4.5M-10%
Ardsley Advisory Partners LP575,0001.58%$3.8MNo change
Lagoda Investment Management, L.P.501,3251.38%$3.3M+14%
Royal Bank of Canada491,4951.35%$3.3M-0%
DAFNA Capital Management LLC260,3600.72%$1.7M-1%
Bleichroeder LP254,7530.70%$1.7MNo change
Formula Growth Ltd240,0880.66%$1.6M-0%
National Bank of Canada218,6980.60%$1.2M+1%
Thompson Davis & Co., Inc.216,5350.60%$1.4M+0%
Dauntless Investment Group, LLC208,3690.57%$1.4M-13%
Raymond James Financial Inc189,1160.52%$1.3M+26%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

No PROF insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

PROF short interest

Low short interest. 4.3% of PROF shares are sold short: about 1 share in 23. Over the last 12 reports the number of shares short went down 28%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 1.58M PROF shares were sold short, 4.3% of the shares outstanding, up 1.4% from the report before. At the average daily volume of 160,809 shares, buying them all back would take about 9.8 trading days (days to cover).

Shares short, % of all shares

4.33%May 15Oct 306.37%

Days to cover

9.8May 15Oct 3047.6

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20261.58M4.33%+1%160,8099.8
Oct 15, 20261.56M4.26%+5%482,8913.2
Sep 30, 20261.48M4.06%-6%124,71511.9
Sep 15, 20261.57M4.30%-3%127,44612.3
Aug 31, 20261.62M4.43%-12%111,91914.5
Aug 14, 20261.84M5.04%+2%114,10216.1
Jul 31, 20261.80M4.97%-3%123,06814.7
Jul 15, 20261.85M5.10%-11%98,98118.7
Jun 30, 20262.07M5.70%-4%59,01935.1
Jun 15, 20262.14M5.91%-3%55,16338.9
May 29, 20262.20M6.07%+1%52,72741.8
May 15, 20262.19M6.02%-6%88,78124.6

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Profound Medical company events

Profound Medical filed 37 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership). The latest was on Nov 9, 2026.

  1. Nov 9, 2026AnnouncementShared information with investors. Filing
  2. Nov 5, 2026ResultsReleased financial results. Filing
  3. Nov 3, 2026AgreementProfound Medical (U.S.) Inc., a wholly owned subsidiary of Profound Medical Corp., entered into a Supply and Distribution Agreement with Cook Medical Holdings LLC, effective as of October 23, 2026. Filing
  4. Oct 22, 2026AnnouncementShared information with investors. Filing
  5. Oct 14, 2026AnnouncementShared information with investors. Filing
  6. Oct 9, 2026AnnouncementShared information with investors. Filing
  7. Oct 7, 2026ResultsReleased financial results. Filing
  8. Sep 4, 2026AnnouncementShared information with investors. Filing
  9. Sep 3, 2026LeadershipProfound Medical Corp. announced that Richard R. Fabian has been appointed by the Board of Directors of the Company to serve as the President of the Company, effective as of the same date. Filing
  10. Aug 17, 2026AnnouncementShared information with investors. Filing
  11. Aug 17, 2026LeadershipProfound Medical Corp. announced that Matthew Sobczyk has been appointed by the Board of Directors of the Company to serve as the Interim Chief Financial Officer of the Company, effective as of the same date. Filing
  12. Aug 13, 2026AnnouncementShared information with investors. Filing
  13. Aug 6, 2026ResultsReleased financial results. Filing
  14. Jul 24, 2026AnnouncementShared information with investors. Filing
  15. Jul 16, 2026AnnouncementShared information with investors. Filing
  16. Jul 15, 2026AnnouncementShared information with investors. Filing
  17. May 15, 2026VoteReported shareholder vote results. Filing
  18. May 14, 2026AnnouncementShared information with investors. Filing
  19. May 7, 2026ResultsReleased financial results. Filing
  20. Apr 16, 2026AnnouncementShared information with investors. Filing
  21. Apr 14, 2026AnnouncementShared information with investors. Filing
  22. Apr 1, 2026AnnouncementShared information with investors. Filing
  23. Mar 27, 2026AnnouncementShared information with investors. Filing
  24. Mar 13, 2026AnnouncementShared information with investors. Filing
  25. Mar 10, 2026LeadershipKris Shah notified the Board of Directors of Profound Medical Corp. of his resignation from the Board, effective immediately. Filing
  26. Mar 9, 2026AnnouncementShared information with investors. Filing
  27. Mar 5, 2026ResultsReleased financial results. Filing
  28. Feb 12, 2026AnnouncementShared information with investors. Filing
  29. Feb 12, 2026AnnouncementShared information with investors. Filing
  30. Feb 5, 2026AnnouncementShared information with investors. Filing
  31. Jan 28, 2026AnnouncementShared information with investors. Filing
  32. Jan 15, 2026AnnouncementShared information with investors. Filing
  33. Jan 12, 2026AnnouncementShared information with investors. Filing
  34. Jan 6, 2026AnnouncementShared information with investors. Filing
  35. Dec 31, 2025AgreementProfound Medical Corp. entered into a subscription agreement with certain Canadian investors providing for the private placement of an aggregate of 921,428 shares of the Company’s common shares, at a per share purchase price of $7.00 for aggregate gross proceeds of $6.45 million. Filing
  36. Dec 19, 2025AgreementProfound Medical Corp., entered into a Securities Purchase Agreement with certain investors, pursuant to which the Company agreed to issue and sell to the Purchasers in a registered direct offering an aggregate of 5,142,870 shares of the Company’s common shares, at a price of $7.00 per share, for… Filing
  37. Nov 28, 2025AnnouncementShared information with investors. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Profound Medical financials

Famous investors that hold PROF

1 of the 50 well-known investors we track reported holding PROF in their latest 13F filing. The largest position is Jim Simons's, worth $67.9K.

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 202611,700$67.9K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Profound Medical Corp. (PROF) stock

Who owns the most PROF stock?

The largest reported owner of Profound Medical Corp. (PROF) is FIL Ltd, with 6.5% of the company. In total, 55 funds and institutions reported holding PROF at the end of Q2 2026, together about 44% of the shares. See the largest owners.

Are PROF insiders buying or selling?

No PROF insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in PROF?

As of Oct 30, 2026, 1.58M PROF shares were sold short, 4.3% of the shares outstanding, up 1.4% from the report before. At the average daily volume of 160,809 shares, buying them all back would take about 9.8 trading days (days to cover). See the history.

Which famous investors hold PROF?

1 of the 50 well-known investors we track reported PROF in their latest 13F filing, including Jim Simons. The largest position is worth $67.9K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.